Compare · 2 funds side by side · dividends reinvested

IBB and GNOM

IBBiShares×GNOMGlobal X×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$14,214IBB · best of the two

02 / 04

IBB and GNOM, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Biotechnology ETFSectors · Technology0.44%0.15%+31.1%+40.7%+25.4%+7.3%−9.6%22.8%$11.2B1.5

Global X - Genomics & Biotechnology ETFSectors · Technology0.50%0.93%+54.5%+62.1%+26.0%−3.6%−18.2%33.5%$109M1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: IBB 2001 · GNOM 2019

Head to Head

Swap sides Versus in desk

Head to Head

iShares Biotechnology ETF · $11.2B$14,214

IBB

GNOM

Global X - Genomics & Biotechnology ETF · $109M$8,342

$10,000 five years ago, dividends reinvested · they hold 24.1% in common

IBBMeasureGNOM

+31.1%Year to dateJan 1 → Nov 4+54.5%

+40.7%1 yearTotal return+62.1%

+25.4%3 years · per year$10,000 became $19,707 · $20,023+26.0%

+7.3%5 years · per year$10,000 became $14,214 · $8,342−3.6%

0.44%Expense ratio$44 · $50 a year on $10k · lower is better0.50%

0.15%Trailing 12-mo yield$15 · $93 a year on $10k0.93%

−9.6%Worst dropSmaller is better−18.2%

22.8%VolatilityLower is calmer33.5%

IBBGNOM Winner of the row, in its colourEach row: the bigger of the two fills its side

4–4Level

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IBB vs GNOM: Top 5 Holdings

Today

IBB

37.0%in top 5

GNOM

in top 533.9%

IBBStockGNOM

5.7%MRNA11.6%

8.9%GILDnot top 5

8.3%AMGNnot top 5

7.5%VRTXnot top 5

6.6%REGNnot top 5

not top 5TWST6.1%

not top 5GH5.5%

not top 5TXG5.4%

not top 5NTRA5.3%

Held in common24.1%

End-of-day Nov 4, 2026 · share of each fund

IBB vs GNOM Returns, Every Period

iSharesIBB

+7.3%

5 years, per year

GNOMGlobal X

−3.6%

5 years, per year

IBBGNOMFaded: behind in that period

1–3GNOM wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

IBB vs GNOM

YTD

iSharesIBB

+31.1%

GNOMGlobal X

+54.5%

+31.1%Year to date+54.5%

−9.6%Worst drop · 1Y−18.2%

22.8%Volatility · 1Y33.5%

0.2%Yield0.9%

$11.2BAssets$109M

2–2level

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IBB, GNOM

Today

0.44%lowest, IBB

FundExpense ratioFee$10k

IBB0.44%$44

GNOM0.50%$50

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: IBB, GNOM

0.93%highest, GNOM

FundTrailing yieldYield$10k

GNOM0.93%$93

IBB0.15%$15

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

$43most kept, GNOM

GNOM$93 − $50 = $43

IBB$15 − $44 = −$29

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: IBB, GNOM

Today

24.1%most shared, IBB and GNOM

IBBGNOM

IBB—24.1%

GNOM24.1%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+62.1%GNOM, at 33.5% volatility

IBBWorst drop−9.6%22.8% vol

GNOMWorst drop−18.2%33.5% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

GNOMIBB

+54.5%Year to date+31.1%

0.9%Yield0.2%

+62.1%Past year+40.7%

0.50%Fee0.44%

3–1GNOM wins

End-of-day Nov 4, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+8.8%

+8.5%Year to date+8.8%

12.2%Yield7.8%

$41.8BAssets$46.0B

1–1level

End-of-day Nov 4, 2026

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$185BAssets$798B

1–0SPYM wins

End-of-day Nov 4, 2026